AbbVie
The Pipeline CSM, Oncology role focuses on supporting investigators in priority sponsored studies and facilitating scientific dialogue about AbbVie's investigational products in a non-promotional manner. This field-based position integrates field insights and clinical development priorities to shape the Korea pipeline medical strategy from early clinical development through approval and launch readiness. The role enhances the company's scientific credibility by collaborating with key investigators, institutions, and cross-functional teams to advance clinical research and medical objectives.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
AbbVie didn’t post a salary, so this is our estimate from similar listings.